StockData
RenovoRx, Inc. logo

RenovoRx, Inc. (RNXT) stock

RNXTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$1.04+0.09 (+8.91%)

Close on Nov 17, 2026Market cap $46.93MP/E –Yield –

RenovoRx profit margin

Profit margin (net margin) is net income as a percentage of revenue.

RenovoRx's profit margin for the twelve months ending Jun 30, 2026 was -621.7%. For fiscal 2025 it was -994.5%, against -20497.7% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-994.5%+19503.2
FY2024Dec 31, 2024-20497.7%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-320.2%+365.8
Q1 FY2026Mar 31, 2026-625.4%+603.0
Q4 FY2025Dec 31, 2025-1235.7%–
Q3 FY2025Sep 30, 2025-1094.7%–
Q2 FY2025Jun 30, 2025-686.0%–
Q1 FY2025Mar 31, 2025-1228.4%–

More RenovoRx figures

See a number that looks wrong?